Published in Hepatitis Weekly, December 12th, 2005
"This study was undertaken to evaluate the possible role of hepatitis B recombinant vaccine inducing the synthesis of IgG and IgM anti-cardiolipin antibodies (aCL), antibodies against beta2 GPI (anti-beta2 GPI), lupus anti-coagulant (LA), anti-nuclear antibodies and antibodies against extractable nuclear antigens (anti-ENA)," wrote J.M. Porobic and colleagues, University of Ljubljana.
"The study population consisted of 85 healthy students (63 female, 22 male; mean age 20.8 years),...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.